For decades, therapeutic monoclonal antibody (mAb) production relied on traditional batch-based manufacturing using stainless steel systems. But as biopharmaceutical pipelines grow to meet rising ...
WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
Breakthrough technology eliminates the recirculation loop to reduce in-process volumes and increase final product concentration, both at high yield PORT WASHINGTON, N.Y., April 20, 2010 - As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results